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Abstract
Background: Racial disparities exist in the care provided to advanced cancer patients. This article describes an
investigation designed to advance the science of healthcare disparities by isolating the effects of patient race
and patient activation on physician behavior using novel standardized patient (SP) methodology.
Methods/design: The Social and Behavioral Influences (SBI) Study is a National Cancer Institute sponsored trial
conducted in Western New York State, Northern/Central Indiana, and lower Michigan. The trial uses an incomplete
randomized block design, randomizing physicians to see patients who are either black or white and who are “typical”
or “activated” (e.g., ask questions, express opinions, ask for clarification, etc.). The study will enroll 91 physicians.
Discussion: The SBI study addresses important gaps in our knowledge about racial disparities and methods to reduce
them in patients with advanced cancer by using standardized patient methodology. This study is innovative in aims,
design, and methodology and will point the way to interventions that can reduce racial disparities and discrimination
and draw links between implicit attitudes and physician behaviors.
Trial registration: https://clinicaltrials.gov/, #NCT01501006, November 30, 2011.
Keywords: Patient-centered communication, Cancer, Racial disparities, Implicit bias, Randomized clinical trial,
Field experiment, Standardized patients, End of life care, Palliative care, Pain management
Background
Racial disparities affect the management of pain for
patients with advanced cancer. Compared to whites
with advanced cancer, blacks with advanced cancer
are prescribed less pain medicine, explaining why
black patients with cancer report a greater pain
burden than do their white counterparts [1]. Potential
contributors to racial disparities in pain management
include differences in patient reporting of pain, differ-
ences in physician assessment of pain, differences in
patient-centeredness of patient-clinician communica-
tion [2, 3], and implicit bias [4].
Physicians report that their own ability to perform an
adequate assessment of pain is a barrier to successful
pain management [5] and that patients have trouble tell-
ing them about their pain in general. These problems
are accentuated with black patients, who, according to
their physicians, do not tend to speak up to tell their
oncologists their concerns [6, 7]. Patient race in the con-
text of physician implicit biases affects physician clinical
decisions and communication behaviors.
Pain assessment is inherently subjective. It relies on
trust in patients’ reports and is influenced by physicians’
implicit stereotypes about black patients. Implicit stereo-
types are developed unconsciously through a lifetime of
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cultural interactions and can surface in the context of
the uncertainty surrounding pain and its assessment and
steer communication (e.g. word choice or eye contact)
and decision-making about pain management in a way
that disadvantages black patients [8]. The automatic
triggering of these implicit biases is enhanced by cogni-
tive overload due to contextual factors such as complex-
ity of disease, complexity of the psychosocial situation,
expressed emotion, racial and cultural differences in lan-
guage use, and co-morbid conditions. Cognitive overload
may be especially relevant for decisions about pain man-
agement because pain management involves clinician
discretion owing to the absence of objective measures of
pain, and paucity of specific clinical practice guidelines.
Stereotypes about black patients are linked to pain
management decisions [8]. Black patients are less likely
than white patients to have their pain documented in
medical records and are less likely to be referred to a
pain specialist. Physicians are more likely order urine
drug tests for black patients and more likely to refer
them to substance abuse treatment [9] despite evidence
that black patients are less likely than white patients to
use opioids for non-medical purposes [10].
Studies suggest that patients who are more assertive
and ask more questions during their visit (“activated pa-
tients”) elicit more patient-centered behaviors from phy-
sicians, including responsiveness to patients’ concerns
and incorporating patients values into decisions [6, 11].
A recent study finds that teaching black patients about
pain management and coaching them to discuss their
needs for pain relief with their physicians results in im-
proved pain control and elimination of disparities be-
tween black and white patients [12]. Such coaching is an
example of patient “activation.” Patient activation may
mitigate racial disparities by promoting patient-centered
communication, yet few studies have examined the effect
of patient activation on disparities in pain management.
Our study, the Social and Behavioral Influences (SBI)
study, is designed to examine both race and patient acti-
vation as factors in pain treatment. The SBI Study is a
randomized field experiment that aims to advance the
science of healthcare disparities in patients with ad-
vanced cancer. This article describes the empirical and
theoretical rationale for the study, the rationale for un-
announced standardized patient (uSP) methodology, SP
role development and fidelity, study measures and study
procedures, the analytic approach and potential implica-
tions of this research.
Theoretical framework
We examine the effects of patient activation, patient-
centered communication, and physician implicit stereo-
types on racial disparities in pain management (along
with secondary outcomes) applying Street’s ecological
model of healthcare communication. An ecological
model considers the context of the visit and the lar-
ger health care system to model the interaction and
mutual influences of patient on physician and phys-
ician on patient [13] (See Fig. 1). In addition, we
draw from Van Ryn’s model of racial disparities [14].
In this model, disparities in pain assessment and
communication are due, in part, to the direct and
moderating effects of patient characteristics, physician
implicit bias, and contextual factors that occur during
clinical conversations. In the SBI study, uSP method-
ology enables us to examine physician factors in com-
munication and decision-making by manipulating
patient factors (race and activation) experimentally
while keeping contextual factors fixed.
Fig. 1 Conceptual model
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Standardized patients are actors trained to portray a
particular role (or roles) in order to minimize, to the
greatest extent possible, inter-patient effects introduced
when studying patient-physician communication in real-
world clinical settings. [15] In designing the SP roles, we
fix contextual factors such as the nature of presenting
problems, level of pain and non-verbal expressions of
distress. In addition, we accentuate cognitive load by
introducing a complex presenting problem, a stigmatized
condition (a smoking-related illness), the potential for
substance abuse, severe distress, and other factors. Mean-
while, patient activation, as reflected in patients’ commu-
nication behaviors, can counteract the effect of physicians’
stereotypes (implicit biases) because it increases
physicians’ personal knowledge of patients and prompts
physicians to involve patients more actively in care.
Based on this framework, we predict that patient acti-
vation will foster individualization of the care that physi-
cians provide and diminution of racial stereotypes as the
physicians become more aware of the patients’ (SPs’)
concerns and values. Theoretically, physicians who see
patients as individuals rather than merely members of a
particular group would engage in patient-centered com-
munication behaviors (e.g., eliciting patients’ concerns,
providing information, being empathic, and responding
to questions). Physicians’ patient-centered communica-
tion behaviors may potentially establish a virtuous cycle
by reinforcing patient activation by encouraging
question asking and participation in decisions.
Current investigation
Building upon the ecological framework, this study will
provide one of the most rigorous tests to date of the ef-
fect of both race and patient activation in pain treatment
disparities. This study addresses the limitations of obser-
vational studies and written and video vignette studies
by employing a randomized experimental design to
examine observed differences in patient physician inter-
action by race and patient behavior, while examining
moderators including physician implicit attitudes. Our
hypotheses are:
1) Physicians’ pain management decisions in advanced
care patients will differ between black and white SPs
portraying identical roles. Specifically, we
hypothesize that black SPs will receive less intensive
pain management, i.e. lower total doses of opioids,
shorter supply of opioids, and less adequate dosing.
2) Physicians’ communication will differ between black
and white SPs. Specifically, we hypothesize that
clinicians will ask the black SP fewer pain questions
and perform a less thorough assessment of the SP’s
pain.
3) Physician differences in behavior by the race of the
SP will be attenuated among SPs portraying the
activated role. Patient activation will mitigate racial
differences in communication behaviors and pain
management decisions.
4) Implicit bias will moderate clinician prescribing and
communication behavior by race.
Methods
Overview
The investigators aimed to recruit individual physicians,
primary care and cancer clinics, and health care sys-
tems via email and telephone, up to 110 primary care
physicians and oncologists from Western NY State,
Central/ Northern Indiana and lower Michigan to
participate who provide consent to participate in an
unannounced SP study of “behavioral and social influ-
ences” on health care. With attrition, our recruitment
goal is 90 physicians, accounting for inability to sched-
ule visits, physician retirements; 90 physicians will
provide adequate power to test our hypotheses. At each
site, we will hire and train four SPs (2 black and 2 white
and two activated and two “typical”) for whom we will
schedule clinic visits with participating physicians. At
the time of the visit, physicians will not know that the
“patient” is, in fact, an SP. Using covert audio record-
ings of the visits and SP ratings, we will assess phys-
ician communication and prescribing behavior in the
management of severe cancer-related pain. We chose
to use only male SPs because evidence suggests that
racial bias against black men is stronger than that
against black women [16, 17], and thus our study aims
would have less risk of being under-powered. The
protocol calls for each physician to see two patients of
the same race because of we did not want to identify
any individual physicians might be identified as provid-
ing differential care based on race.
The study procedures are separated into four steps.
Before the study begins, we pilot each step of the study
across all three sites. The Western New York site was
slated to begin recruiting physicians and deploying SPs
during years 1 and 2, followed by the Indiana site in
years 2 and 3 and Michigan in years 3–5. Physicians re-
cruited to the study complete a consent form for par-
ticipation, a physician questionnaire; they also identify
an office liaison to work with the study coordinators at
each site to help with scheduling, medical records and
canceling tests and follow-up appointments. At least 4
months after recruitment, the first of 2 SP visits is con-
ducted, followed by the second visit at least 4 months
later (see Visit Procedures for additional details). Ap-
proximately 2 months after the physician sees the sec-
ond SP, we send the physician an email or fax asking
whether they suspect that they have seen an SP; then
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the study team requests a copy of the SP’s record and
study physicians complete an online Implicit Associ-
ation Test designed specifically for the study.
Selection of study sites
We chose to recruit physicians from three geographic
regions with corresponding differences in communities,
healthcare systems, and local practice culture. The
Western New York region is a mix of urban and subur-
ban sites with a substantial population of African-
Americans and Latinos, a broad socioeconomic mix and
a mixture of University-based and private oncology prac-
tices and community-based primary care practices. The
North-Central Indiana region is in the heart of rural In-
diana with a mixture of large health care organizations
and community based practices that are being integrated
into larger healthcare systems. The Michigan oncology
practices are community-based; the primary care physi-
cians are recruited from two large health systems.
Eligibility, recruitment, consent
We obtained IRB approval from each of the correspond-
ing academic institutions and medical systems prior to
physician recruitment. The study is designated as a de-
ception study at the University of Michigan but not at
the two other sites. Participating physicians sign written,
informed consent. Complete inclusion and exclusion cri-
teria are presented in Table 1, and participant eligibility
is verified before consent.
At each site, we recruit medical oncologists who care
for patients with solid (non-hematologic) cancers and
primary care physicians (family medicine physicians and
internists) using email, telephone and in-person meet-
ings. We deploy SP visits to oncologists first, in order to
avoid primary care referrals to oncologists who could
potentially be scheduled to see SPs in the same or neigh-
boring networks, hospitals, or physician practices. Inter-
ested physicians meet with the study personnel (site PIs,
study coordinator, and/or research assistant) to learn
about the project, provide written consent, and complete
the baseline surveys. The consent document seeks each
oncologist’s agreement to 1) complete initial baseline
questionnaires, 2 & 3) complete two patient visits with
unannounced SPs, during the next 18–24 months after
consent, that are covertly audio-recorded, 4) a
standardized patient detection form and the Pain Impli-
cit Attitudes Test, a modified version of the well-known
IAT, [18], at least a month after the two visits. Physicians
are told that the SBI study “examines social and personal
factors that affect clinical care and outcomes” and that
these factors might include “patient age, gender, race/
ethnicity, income, education, communication style, dis-
ease, symptoms, and functioning, as well as physician
factors.” Further, we inform physician participants that
the study would “identify communication behaviors that
improve mutual understanding between patients and
physicians.” Once physicians agree to participate, we ask
them to provide the name of an office liaison. The con-
sent document describes the four steps of the study. Par-
ticipating physicians receive $600 for completing all
steps of the study ($150 for each step completed).
Because of increased scrutiny of patient identification,
we work closely with practice managers to establish
what would qualify as an acceptable photo ID (such as a
work badge) or create work-arounds so that patients
would not have to show a photo ID at all; clearly, creat-
ing false state or federal identification cards would not
be permissible. Similarly, we create false callback num-
bers for patients and devise methods for checking phone
mail and responding accordingly.
Standardized patient roles
We hire and train two sets of white SPs and two sets of
black SPs at each site. The four SP roles at each site in-
clude 1) a black individual who portrays an activated pa-
tient, 2) a black individual who portrays a typical
patient, 3) a white individual who portrays an activated
patient, and 4) a white individual who portrays a typical
patient. Both black and white activated and typical pairs
portray them identically. In order to further standardize
the role and where possible, actors are matched on phys-
ical appearance and interpersonal style when assigning
them to the typical versus active SP role. SPs report at
each visit that they were treated for lung cancer in an-
other state and that they moved to be closer to one of
their adult children, explaining their need to find a new
physician. The SPs report bony pain, rated 7 out of 10,
not relieved by current medication such that they have
been taking more than the prescribed doses due to escal-
ating pain. For the past 2 weeks, SPs report taking 2
Table 1 Inclusion and exclusion criteria for oncologists and primary care physicians
Participant Inclusion criteria Exclusion criteria
Oncologist Oncologists that care for patients with solid tumors
and who would likely see a patient with lung cancer
Not planning to leave the practice or retire within
the next year
Non-physicians, Oncologists who exclusively care for
patients with hematologic malignancies, those who
specialize in exclusively genitourinary, breast, hematologic
and neurologic cancers.
Primary Care Not planning to leave the practice or retire
within the next year
Non-physicians
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tablets of hydrocodone 5 mg /acetaminophen 500 mg
(Lortab® or Vicodin®) every 3 h instead of 2 every 4 h as
prescribed. The four SP roles created are identical except
for two factors – SPs’ race and patient activation, as
shown in Table 2.
Activation is operationalized in this study according to
behavioral criteria developed by Street et al., Hibbard et
al., and Kaplan et al. [19–22]. Activated SPs ask more
direct questions about their pain management, their
prognosis, and the risks and benefits of pain medica-
tions. They request information, ask questions when
they do not understand, and redirect the discussion
when their concerns are not addressed. (see Table 3) In
addition, activated SPs are trained to bring a list of ques-
tions, express at least one concern about side effects of
treatment and or prescription modifications, and inter-
rupt the physician at least once to ask for more informa-
tion. If the physician has already provided the answer to
an activated SP question before the SP asks it, the acti-
vated SP has been trained to use supplemental questions
that invite further clarification from the physician in
order to make sure that an activated SP role is por-
trayed. Using a series of pilot visits, activated patients’
role presentations are calibrated so they do not appear
demanding or question the physician’s competence.
Typical patients are not as engaged in care, as evidenced
by questions only about how to follow through with
treatment, relatively few emotional concerns expressed,
general satisfaction with information presented, and
indicating understanding without asking follow up
questions.
Standardized patient training
Each site is responsible for hiring SPs. SPs receive 50 h
of training in the role before deployment, including a
3-day intensive training at the University of Rochester,
Purdue University, or the University of Michigan with
the PIs and the trainers from all 3 sites. During train-
ing, roles are piloted at all sites with clinicians who are
unaware of the study hypotheses in order to achieve
roles sufficiently distinct, credible, unlikely to raise sus-
picions that the patient is an SP, and unlikely to intro-
duce other confounding concerns (e.g., mental illness).
For this study, we build on the clinical biography and
extensive script developed for the pilot study. [23] The
detailed script, which we use to standardize training at
all three sites, describes likely physician questions and
appropriate SPs responses to physician questions.
During the first months of this project, we review and
update both roles and ask for feedback from local
experts at each site to ensure that the roles are psycho-
logically and medically believable. Training focuses on
learning the biographical details and portraying the
attitudes and emotions of the role.
SPs are monitored throughout the study to maintain
90% or higher role fidelity using a fidelity rating scale.
The scale includes content items that assess the accur-
acy of the facts presented as well as rating scales to
calibrate tone of voice, level of emotionality portrayed,
and non-verbal pain behaviors. In addition, SPs receive
active training during the time visits are taking place.
Activated SPs are trained separately from the typical
SPs, and the roles are not at any time shared or dis-
cussed with SPs portraying the other role. All SPs are
blinded to the study hypotheses and are not told that
activation or race are related to the study hypotheses.
To monitor fidelity and offer ongoing feedback during
data collection, SP trainers listen to audio-recordings
within 2 business days of each visit for the first 15
visits, after every third visit thereafter, and more
frequently if needed for feedback to the SPs.
Randomization of SPs
We employ an incomplete randomized block design in
which each block does not receive all treatments. Each
physician is visited by 2 different SPs, both of the same
race, but differing according to activation. Each phys-
ician experiences 2 of the 4 possible SP roles – either a)
black activated and black typical (non-activated), or b)
white activated and white typical; the order of presenta-
tion of the SPs is randomized, such that half of the phy-
sicians see the activated SP first, and the other half see
the typical SP first. Visits are at least 4 months apart.
Visit and standardized patient procedures
We arrange all visits through the office liaison in order
to manage anticipated problems such as insurance verifi-
cation and identity checks. The office liaison agrees to
arrange “detours” around usual administrative details
Table 2 SP Characteristics by Race and Activation Level
Standardized
Patient Race
Activation
Level: High
Activation
Level: Low
Total N
of SPs
Black 1 1 2
White 1 1 2
Total N 2 2 4
Table 3 Sample Activated SP Questions & Comments
1. I am wondering if I should be taking more pain
medication – should I?
2. You know, the pain seems to be getting more bothersome.
Does the pain medication stop working after a while?
3. Am I going to get addicted to the medication?
4. I know things are not good, but can you be realistic about what’s the
best case scenario and what’s the worst case?
5. What are my options at this point? You know, I really prefer to be
comfortable at this point.
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that office staff members might raise. We stress to the
office liaison about the importance of not disclosing the
identity of the SP to anyone in the office who might in-
form the physician. If the practice has been closed to
new patients, the study coordinator works with the of-
fice liaison to devise a plausible excuse (e.g., stating that
the SP is the relative of a current patient) to include the
patient on the physician’s office schedule.
Before each physician visit, the SP meets with the SP
trainer or study coordinator for a pre-visit meeting to go
over details about the role and obtain necessary docu-
ments (ID card, insurance card, medication lists, recent
labs, etc.) and recorders. SPs also review office logistics
and new patient handouts if available. About 1 week
prior to the visit, participating physicians are sent mock
medical records, with fake contact information for phy-
sicians and clinics. If physicians follow up on the contact
information, they would encounter convincingly de-
signed mock websites, and phone numbers with phone
trees that ultimately ask the caller to leave a voice mail.
On arrival to the office, SPs activate audio recorders
and present (fake) photo IDs and/or insurance cards. In
some cases, office liaisons advise the study coordinators
to avoid using insurance cards and to develop story
lines about self-pay or billing out-of-state insurance
after the visit due to concern about tipping off office
staff or the physician about SP identity. The office staff
registers the SP and creates an electronic or paper
medical record as if the SP’s were a real patient visit.
The SP role includes cooperation with all aspects of the
visit, but the SP declines any invasive medical proce-
dures (e.g., blood draws) and any radiographic studies;
they also decline any oral, topical or injectable medica-
tions that might be offered during the visit. SPs carry
fabricated reports of recent laboratory studies to avert
blood draws during the visit.
Immediately following the visit, study coordinators
void any prescriptions using a rubber stamp “VOID,”
complete an SP Post-Visit Reporting Form assessing spe-
cific elements of history taking, physical examination,
and medical decision-making, and meet with the study
coordinator to return all materials (audio-recorder, pre-
scriptions, questionnaire, ID cards, after visit summaries,
lab requisitions, billing information and post visit mea-
sures). They debrief with the SP trainer after each visit
about how the SPs thinks the visit went, if there were
any logistical problems, any difficulties encountered in
the visit, or any problems portraying the role.
We intercept electronic prescriptions by calling the
pharmacy to cancel them. Either the SP or a research
team member cancels all scheduled lab tests and follow-
up appointments. Some offices will not release the
prescriptions after the SP completes the physician visit
so we make arrangements to leave them with office
liaisons at checkout. Office staff are notified that the SP
would not be returning (various alibis are provided –
e.g., that patient is going to move in with a relative in
another part of the state, chose another physician, etc.),
and the office is instructed to cancel any follow-up ap-
pointments, procedures, or case conferences. Physician
office staff treats records (electronic or paper) as they
would for a real patient who would not be returning to
the office. Approximately 2 months after the physician
sees both SPs, we send the physician an email or fax ask-
ing whether they suspect that they had seen an SP. After
seeing two SPs and completing the detection informa-
tion, the study team requests a copy of the SP’s record.
The Pain IAT is administered immediately afterwards.
Physicians are given the option to complete the IAT on
a personal computer or have the research assistant bring
a computer to the office to complete the IAT. We
describe these instruments in more detail below.
Outcome measures
Pain medication prescribing
The primary outcome for this study is physicians’
management of patients’ cancer pain. First, we calculate
from prescriptions the total daily prescribed dose of each
medication and, for opioids, total daily morphine equiva-
lent using standardized opioid conversion charts. When
medications are written “prn” or “as needed,” our calcu-
lations assume that all doses would be taken. We also
calculate the total number of doses dispensed. We also
made note of non-opioid medications prescribed, al-
though these were not related to the primary study
hypotheses.
Physician-standardized patient communication
The audio-recorded office visits are coded using behav-
ioral coding systems for Pain Assessment, Prognosis and
Treatment Choice Communication, and Eliciting and
Validating Concerns [24]. The Measure of Pain Assess-
ment (MPPA) examines the degree to which physicians
assess patient pain based on items used in self-report
questionnaires. [25–28] and assessments of patient-
clinician communication [29–33] The instrument is used
in the pilot study to measure the thoroughness of physi-
cians’ assessment of patients’ pain. Examples of items
are “onset” (when start and duration), “location,” and
“intensity/severity.” We will assess prognosis and treat-
ment choice communication from the audio-recordings
using the PTCC, which we developed in our pilot and
recently used in a large randomized intervention trial to
improve communication in advanced cancer [34]. These
items assess physicians’ communication of diagnostic
and prognostic information and the treatment options
that may be offered to advanced cancer patients. Sample
items are “Physician asks if patient wants to know more
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about his or diagnosis” and “Assessing if patients under-
stand their diagnosis.” These items are coded using the
same physician response scale used to measure the
depth of pain assessment (MPPA). See Tables 4 & 5 for
PTCC and MPPA items.
Physician survey measures
The physician measures completed at the time of enroll-
ment and consent are outlined in Table 6. Physician
demographics include age, gender, race, specialty and
training information (i.e., board certification, fellowships
completed) and practice information (number of pa-
tients seen per week, make-up of patient population,
ownership of practice, type of provider plans practice
participates in, use of an EHR, practice location, etc.)
Physician burnout is measured using the emotional ex-
haustion subscale from the Maslach Burnout Inventory
(MBI) [35, 36]. The MBI is widely used and validated
with healthcare personnel. Physician empathy was
measured using the perspective-taking subscale of the
Jefferson Scale of Physician Empathy (JSPE)-A
Empathy. The JPE is based on a cognitive definition of
empathy (e.g., the physician understands the patient’s
experience) and reports good reliability [37].
Physicians’ beliefs about psychosocial aspects of pa-
tient care are assessed using the Physicians’ Beliefs about
What Patients Want 6-item subscale of the Physician
Belief Scale. Higher scores reflect physicians’ belief that
patients’ psychosocial issues are a part of a physician’s
role [38, 39]. We developed a 3-item scale asking about
comfort with prescribing opioids. Items include, “In gen-
eral, I am more reluctant to prescribe opioids for pain
than my colleagues are.” We used the Baer Mindfulness
scale to measure two facets of mindfulness - observing
(8 items) and non-reactivity (7 items) [40]. The Relation-
ship Questionnaire assesses adult attachment styles [41].
The Need for Closure (NFC) scale assesses the tendency
to rely on cognitive biases when making decisions, and
correlates with racial biases. The NFC moderates the as-
sociation between intergroup contact and negative racial
attitudes [42]. At least 1 month after completing the
second SP visit, physicians complete the Implicit Associ-
ations Test (IAT), adapted for this study from prior vali-
dated versions of the IAT. The IAT measures implicit
biases using automatic association tests to assess how
the brain links concepts. While the classic race IAT [18]
has been widely used, we developed a healthcare focused
IAT more relevant to assess implicit biases in physicians.
Adding the task of recognizing pain to the classic race
IAT creates a measure examining implicit bias in regards
to race and pain management.
Standardized patient questionnaire
After completing each visit, SPs are asked to rate their
satisfaction with overall care, quality of pain discussion,
and quality of prognosis discussion on a 6-point Likert
scale. SPs are asked whether the physician prescribed
pain medication at the visit and their perception of how
reluctant or enthusiastic the physician was about pre-
scribing the medication using a 5-point Likert scale.
SPs also answer questions from the Jefferson Scale of
Patient Perceptions of Physician Empathy (JSPPPE) [43].
The JSPPPE is a brief five-item scale developed for
measuring patient perceptions of their physician’s
empathy. Patients respond using a 7-point Likert scale
(1- strongly disagree, 7 – strong agree).
SPs report nonverbal communication using a measure
developed for the study. The measure consists of seven
questions scored on a five point Likert scare (1 = poor,
5 = excellent). Items include “the physician maintained
appropriate eye contact with me;” “looked at me instead
of a computer/laptop/tablet screen/charts;” and
“gestured/nodded their head at me when appropriate.”
The study team trains all SPs regarding definitions of
Table 4 PTCC Items
Items
1. Cancer Knowledge: Assessing patient’s knowledge of state of disease
2. Open Door: Asking if the patient wants to know about the prognosis,
survival, curability/the future or indicating common questions that
people have about the prognosis, survival, curability, future quality
of life, or palliative care.
3. Understand Prognosis: Assessing the patients’ understanding of
their prognosis.
4. Changing for the Worse: Discussion of how the disease trajectory
is changing for the worse.
5. Quality of Life: Discussion of quality of life in the future
6. Palliative Care: Discussing palliative care treatment
7. Advanced Directives: Discussing advanced directives
8. Curability: Discussing if the cancer can be cured.
9. Survival Time: Discussing estimates of survival time.
10. Best Worst Case: Discussing best case and worst case scenario
11. Double Frame: Double Framing Survival/Curability Estimates
Table 5 Measure of Physician Pain Assessment Items
Physician Discussing or Asking about
1. Acknowledging pain
2. Onset, duration, temporal
3. Location
4. Aggravating /alleviating factors
5. Pain Origins
6. Interference
7. Description of Pain
8. Rate pain on 0–10 scale
9. Physician Role in Pain Management
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nonverbal communication to increase reliability of
reporting nonverbal behaviors.
SPs assesses physician’s communication skills using
the Rochester Communication Rating Scale, [44] a 19-
item scale developed to assess patient-centered commu-
nication skills of physicians. Components of patient
centered care that are assessed from the patients
perspective include eliciting the patient’s perspective, un-
derstanding the psychosocial context, developing a col-
laborative relationship and activity involving the patient
in decisions about his or her health.
We use a Role Fidelity Form to assess SPs accuracy to
the role. Portrayals are calibrated during the 30 h of exten-
sive training to achieve greater than 90% role accuracy on
a 100–point role fidelity scale that includes measures of
verbal content and emotional valence of the role.
Sample size determination
Our sample size goal is 91 physicians, assuming that 158
visits will have been conducted in total, accounting for
attrition. Statistical power is estimated for the fixed
effects corresponding to primary study hypotheses using
a mixed-effects model with a random intercept captur-
ing between physician variance. We assume moderate
nesting of outcomes within physician (intra-physician
correlation coefficient (ICC) of 0.3 to 0.5). The effective
sample sizes resulting from 158 repeated observations
and ICC = 0.03 are 122 for a physician level effect and
226 for a within-physician effect, e.g., activation and
activation-by-SP race interaction effects [45]. The effect-
ive sample sizes resulting from 158 repeated observa-
tions and ICC = 0.05 are 105 for a physician level effect
and 316 for a within-physician effect. Given this, a phys-
ician effect equivalent to a standardized regression coef-
ficient of 0.25 and 0.27 can be detected with power of
0.8 for ICC of 0.3 and 0.5, respectively. A within-
physician effect equivalent to a standardized regression
coefficient of 0.16 and 0.19 can be detected with power
of 0.8 for ICC of 0.5 and 0.3, respectively. Outcomes
with higher levels of nesting will result in less statistical
power at the physician level and more statistical power
at the within-physician level.
Table 6 Schedule of Measures completed by physicians, Coders, & Standardized Patients
Domain Measure Study
entry
Post
Visit 1
Post
Visit 2
2–4 month
Follow up
Physician Questionnaires / Measures
Demographics Age, gender, race, specialty, practice information, etc. x
Physician Burnout Maslach Burnout Inventory (MBI) x
Physician Empathy Jefferson Scale of Physician Empathy (JSPE)-
Perspective Taking Subscale
x
Psychosocial Aspects
of Physician Care
Physician Belief Scale (PBS)– Burden Subscale x
Mindfulness Observing and non-reactivity subscales x
Attachment RQ Attachment Scale x
Need for Closure Need for Closure Scale (NFC) x
Comfort Prescribing
Pain Medication
PAROPM (developed for this study) x
After Visit Physician Measures
Prescriptions Extracted from prescriptions given to SPs x x
Detection Fax Sent to physician 3 weeks after last SP visit X
IAT Pain Implicit Associations Test x
SP Questionnaires
Measures SP perception of patient empathy, satisfaction with overall care, quality of
pain discussion, quality of prognosis discussion, physician nonverbal,
Rochester Physician Communication Scale
x x
Coding of Transcripts from Audio Recordings
Pain Coding Measure of Physician Pain Assessment X x x
Prognosis Coding Prognostic and Treatment Choices (PTCC) x x x
Shared Decision Making SDM Coding Scale [44] x x x
Eliciting and Validating
Patient Concerns
Exploring and Validating Patient Concerns x x x
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Planned analytic approach
Our primary analytic method will be generalized mixed-
effects regression modeling using a random intercept to
adjust for within physician nesting of outcomes. In these
models, associations between predictor variables and
study outcomes will be estimated with fixed-effect
regression coefficients.
Discussion
The SBI study addresses important gaps in our knowledge
about racial disparities in pain management between
white and black patients with pain due to advanced cancer
and potential effects on physician behavior of patient acti-
vation. It also provides information about potential mech-
anisms of these disparities, including physician
demographics, explicit physician attitudes (e.g., towards
opioid prescribing and patient-centered care), physician
psychological attributes (e.g. mindfulness and need for
certainty), and physicians’ implicit associations regarding
race and pain management (measured using the IAT). We
use novel standardized patient methodology to control
variability in patient presentation. This study is innovative
in aims, design, and methodology and will point the way
to interventions that can reduce racial disparities and dis-
crimination and draw links between implicit attitudes and
physician behaviors that have not yet been investigated.
We have addressed several threats to external validity
of the study. By triangulating three different operationa-
lizations of activation, we produce a role that aggregates
all of them, presented in moderation so that the acti-
vated role is credible and not seen by physicians as ag-
gressive or demanding. We create plausible false medical
records that are reviewed by oncologists and primary
care physicians for authenticity, and were rarely ques-
tioned when deployed in our pilot work. We create cred-
ible false websites and contact information for the
purported physician and clinic where the standardized
patient claimed to have received care, including phone
mail. The attention to these kinds of details makes an
otherwise difficult study credible.
We have overcome several logistical challenges to
implementing the SBI study. In prior SP studies, physi-
cians could be approached directly to gauge their inter-
est in participating, with few exceptions. In the current
study, we have to go to large integrated health systems
and address the concerns of clinical directors respon-
sible for up to 300 potential physicians, especially their
concerns regarding the impact of the study on work flow
and billing. Thus, refusal by one administrator could po-
tentially disqualify hundreds of physicians. Nonetheless,
we will have achieved recruitment targets that provide
adequate power for analyses; the physician sample is
diverse and reflects the physician population in those
regions.
Even if we fail to confirm the main study hypotheses,
the study will provide a rich dataset for examining sec-
ondary hypotheses that link physician self-ratings and
their observed behavior. For example, the degree to
which physicians have insight into their own communi-
cation behaviors is not clear and we can find answers by
triangulating self-report and audio-recorded data about
communication style. Failure to identify racial disparities
in prescribing can identify the degree to which pain pre-
scribing in cancer is seen as discretionary (and thus
more subject to bias), and may stand in contrast to pre-
scribing for non-cancer conditions, such as chronic low
back pain, in which the majority of pain disparities
research has been conducted. We have an opportunity
to determine whether activation has differential effects
on communication depending on whether the patient is
black or white.
Finally, we have the opportunity to investigate in
greater depth systems issues in providing care to
patients in pain and those with advanced cancer. By
charting their journey through the health care systems –
tests, referrals, prescriptions, and other patient instruc-
tions – we can identify important gaps in care.
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